CORESTEMCHEMON Inc. (KOSDAQ:166480)
1,754.00
-27.00 (-1.52%)
At close: Jul 21, 2026
CORESTEMCHEMON Market Cap
CORESTEMCHEMON has a market cap or net worth of 77.81 billion as of July 21, 2026. Its market cap has decreased by -7.82% in one year.
Market Cap
77.81B
Enterprise Value
112.38B
Revenue
18.39B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,754.00
ChartMarket Cap Chart
Since June 26, 2015, CORESTEMCHEMON's market cap has decreased from 653.85B to 77.81B, a decrease of -88.10%. That is a compound annual growth rate of -17.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 77.81B | -5.09% |
| Dec 30, 2025 | 81.98B | -13.27% |
| Dec 30, 2024 | 94.52B | -34.79% |
| Dec 28, 2023 | 144.95B | -43.25% |
| Dec 29, 2022 | 255.40B | -13.00% |
| Dec 30, 2021 | 293.58B | -19.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cell Biotech | 102.93B |
| NovMetaPharma | 92.46B |
| Choong Ang Vaccine Laboratory | 86.36B |
| BIO-FD&C | 71.39B |
| SunBio,Inc. | 69.75B |
| QuadMedicine | 68.20B |
| CTCBIO | 67.90B |
| EyeGene | 64.11B |